# Major Recall Alert: Medicines Declared Not of Standard Quality (NSQ) by the Central Drugs Standard Control Organization (CDSCO) India
Consumers and healthcare professionals in Nigeria, be alert! The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent warning following a declaration by the Central Drugs Standard Control Organization (CDSCO) in India. Over 100 medicines produced by multiple companies have been labeled as Not of Standard Quality (NSQ). Immediate action is necessary to ensure safety and prevent adverse consequences.
## Why This Recall is Important
The quality and safety of medicines are critical for public health, especially when dealing with life-saving drugs. Substandard medicines can lead to ineffective treatments, prolonged illnesses, or even dangerous side effects. This recall affects Nigeria due to the import and distribution of these products. Healthcare professionals, distributors, retail pharmacies, and consumers must prioritize safety by avoiding the use of the listed products.
The medicines flagged as NSQ were manufactured by multiple brands, raising concerns about the integrity of these products in international supply chains. The recall serves as a critical reminder of the importance of sourcing medicines from trusted and verified suppliers.
## Details of the Recall
Here’s what you need to know about this significant recall:
- **Category:** Medicines declared Not of Standard Quality (NSQ) by CDSCO India.
- **Brands Affected:**
- Abaris Healthcare Pvt Ltd
- Alencure Biotech Pvt Ltd
- Eurolife Healthcare Pvt Ltd
- Health Biotech Ltd
- HIGGS Healthcare
- Kamataka Antibiotics & Pharmaceuticals Ltd (KAPL)
- Laborate Pharmaceuticals India Ltd
- Legend Industries
- Martins & Brown Biosciences Pvt Ltd
- Mascot Health Series Pvt Ltd
- Micron Pharmaceutical
- Orison Pharma International
- Rivpra Formulation Pvt Ltd
- Sai Parenterals Ltd
- Symbiosis Pharmaceuticals Pvt Ltd
- Syncom Formulations (India) Ltd
- Zee Laboratories Ltd
- **Recall Reason:** Labeled as Not of Standard Quality (NSQ) by the CDSCO India due to quality control failures.
- **Date Announced:** October 2023.
For the latest update on the affected products, you can refer to the [official NAFDAC notification here](https://nafdac.gov.ng/public-alert-no-14-2025-alert-on-the-declaration-of-over-100-medications-as-substandard-by-indian-authorities/).
## What You Should Do
Healthcare providers, retailers, and consumers should take the following steps immediately to avoid potential medication risks:
- **Importers & Distributors:**
- Cease transactions with the listed manufacturers.
- Verify the origin of all imported pharmaceutical products.
- **Retailers & Pharmacies:**
- Avoid stocking medicines originating from the affected companies.
- Return substandard products to suppliers where possible.
- **Healthcare Professionals:**
- Cross-check the origin of medications before prescribing or administering them to patients.
- Report any suspected substandard medications to NAFDAC immediately.
- **Consumers:**
- Check medication labels for the manufacturers listed above.
- Avoid using products from these companies and consult your healthcare provider for alternatives.
Ensuring compliance with this recall helps protect public health and prevents potential harm caused by substandard pharmaceuticals.
## Stay Safe – Get Instant Recall Alerts
Don’t wait until it’s too late. Stay informed about recalls, public alerts, and product safety updates with the MyRecalls app. With features tailored to provide instant notifications and detailed recall information, you can ensure your safety and that of your loved ones.
👉 **[Download the MyRecalls App Now](https://myrecalls.app)** for enhanced protection and up-to-date alerts.
Risk management starts with knowledge. By taking action to avoid these NSQ medicines, we collectively play a role in safeguarding public health in Nigeria.
For more details on global medicine recalls and safety updates, visit the official [NAFDAC website](https://nafdac.gov.ng/public-alert-no-14-2025-alert-on-the-declaration-of-over-100-medications-as-substandard-by-indian-authorities/) regularly. Stay informed, stay safe!